How should we manage incidental meningiomas?
作者信息
Nassiri Farshad, Zadeh Gelareh
机构信息
Division of Neurosurgery, University Health Network, University of Toronto, and MacFeeters-Hamilton Center for Neuro-Oncology, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
出版信息
Neuro Oncol. 2020 Feb 20;22(2):173-174. doi: 10.1093/neuonc/noz237.
Abstract
摘要
相似文献
1
How should we manage incidental meningiomas?
Neuro Oncol. 2020 Feb 20;22(2):173-174. doi: 10.1093/neuonc/noz237.
2
[Clinicoradiological studies and frequency of incidental meningiomas on brain check-up].
Brain Nerve. 2008 Mar;60(3):273-8.
3
Incidental meningiomas in autopsy study.
Surg Neurol. 1987 Apr;27(4):319-22. doi: 10.1016/0090-3019(87)90005-x.
4
Clinicopathologic features of incidental meningiomas: A review of the literature and the University of Rochester autopsy experience.
Clin Neuropathol. 2019 May/Jun;38(3):118-121. doi: 10.5414/NP301160.
5
Overexpression of STMN1 is associated with the prognosis of meningioma patients.
Neurosci Lett. 2017 Jul 27;654:1-5. doi: 10.1016/j.neulet.2017.06.020. Epub 2017 Jun 16.
6
Meningioma size. Its relationship to other diseases.
Arch Neurol. 1981 Jul;38(7):458-9. doi: 10.1001/archneur.1981.00510070092019.
7
SPARC and Vav3 Expression in Meningioma: Factors Related to Prognosis.
Can J Neurol Sci. 2013 Nov;40(6):814-8. doi: 10.1017/s0317167100015948.
8
[Meningiomas: new prognostic factors].
An R Acad Nac Med (Madr). 2007;124(2):319-32; discussion 330-2.
9
Incidental Meningiomas: Management in the Neuroimaging Era.
Neurosurg Clin N Am. 2016 Apr;27(2):229-38. doi: 10.1016/j.nec.2015.11.012.
10
Incidental meningiomas.
Neurosurg Focus. 2011 Dec;31(6):E19. doi: 10.3171/2011.9.FOCUS11220.
引用本文的文献
1
Clinical Management of Supratentorial Non-Skull Base Meningiomas.
Cancers (Basel). 2022 Nov 29;14(23):5887. doi: 10.3390/cancers14235887.
本文引用的文献
1
Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival.
Neurooncol Adv. 2019 May-Dec;1(1):vdz011. doi: 10.1093/noajnl/vdz011. Epub 2019 Aug 28.
2
A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas.
Neuro Oncol. 2020 Feb 20;22(2):278-289. doi: 10.1093/neuonc/noz160.
3
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.
Neuro Oncol. 2019 Jul 11;21(7):901-910. doi: 10.1093/neuonc/noz061.
4
Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes.
J Neurooncol. 2019 Apr;142(2):211-221. doi: 10.1007/s11060-019-03104-3. Epub 2019 Jan 17.
5
Challenges and opportunities in meningiomas: recommendations from the International Consortium on Meningiomas.
Neuro Oncol. 2019 Jan 14;21(Suppl 1):i2-i3. doi: 10.1093/neuonc/noy181.
6
DNA methylation-based classification of central nervous system tumours.
Nature. 2018 Mar 22;555(7697):469-474. doi: 10.1038/nature26000. Epub 2018 Mar 14.
7
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.
Neuro Oncol. 2016 Oct 1;18(suppl_5):v1-v75. doi: 10.1093/neuonc/now207.
8
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Lancet Oncol. 2017 May;18(5):682-694. doi: 10.1016/S1470-2045(17)30155-9. Epub 2017 Mar 15.
9
Integrated genomic analyses of de novo pathways underlying atypical meningiomas.
Nat Commun. 2017 Feb 14;8:14433. doi: 10.1038/ncomms14433.
10
Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.
Acta Neuropathol. 2017 Mar;133(3):431-444. doi: 10.1007/s00401-017-1678-x. Epub 2017 Jan 27.
Zotero 插件